Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LTC004 in Patients With Advanced or Metastatic Malignancies

NCT05666635 is registered in ClinicalTrials.gov with Letolab as lead sponsor.

NCT NCT05666635
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05666635 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LTC004 in Patients With Advanced or Metastatic Malignancies
Lead sponsor
Letolab
Phase
Phase 1
Overall status
Unknown status
Start date
December 31, 2022
Completion date
December 31, 2024
Enrollment
368 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

adult solid tumor